FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
OFIRMEV
acetaminophen
Peak
INTRAVENOUS · SOLUTION
2010
NDA0/100
OLINVYK
oliceridine
Peak
Trevena
INTRAVENOUS · SOLUTION
for whom alternative treatments are inadequate
2020
NDA0/100
OLPRUVA
sodium phenylbutyrate
Peak
ORAL · FOR SUSPENSION
2022
NDA0/100
OLUMIANT
baricitinib
Peak
Eli Lilly and Company
ORAL · TABLET
2018
SMNDA0/100
OMEPRAZOLE
omeprazole
Peak
Bridge Therapeutics
ORAL · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
2017
SMNDA0/100
OMIDRIA
phenylephrine and ketorolac
Peak
IRRIGATION · SOLUTION
2014
NDA0/100
OMLONTI
omidenepag isopropyl
Peak
ExThera Medical
OPHTHALMIC · SOLUTION
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+1
2022
NDA0/100
ONGENTYS
opicapone
Peak
ORAL · CAPSULE
2020
NDA0/100
ONIVYDE
irinotecan hydrochloride
Peak
Ipsen
INTRAVENOUS · INJECTABLE, LIPOSOMAL
2015
NDA0/100
ONPATTRO
patisiran
Peak
Alnylam Pharmaceuticals
INTRAVENOUS · SOLUTION
the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults
2018
RNANDA0/100
ONZETRA XSAIL
sumatriptan succinate
Peak
Currax Pharmaceuticals
NASAL · POWDER
cluster headache () Limitations of Use Use only if a clear diagnosis of migraine has been establishedmigraine attacks+1
2016
NDA0/100
OPZELURA
ruxolitinib
Peak
Incyte
TOPICAL · CREAM
atopic dermatitis
2021
SMNDA0/100
ORBACTIV
oritavancin
Peak
CorMedix
INTRAVENOUS · POWDER
2014
NDA0/100
ORENITRAM
treprostinil
Peak
United Therapeutics
ORAL · TABLET, EXTENDED RELEASE
pulmonary arterial hypertension (PAH) (WHO Group 1) to delay disease progressionto improve exercise capacity+1
2013
NDA0/100
ORFADIN
nitisinone
Peak
Swedish Orphan Biovitrum
ORAL · SUSPENSION
2016
NDA0/100
ORGOVYX
relugolix
Peak
Sumitomo Dainippon Pharma
ORAL · TABLET
2020
NDA0/100
ORIAHNN (COPACKAGED)
elagolix and estradiol and norethisterone
Peak
AbbVie
ORAL · CAPSULE
heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women
2020
NDA0/100
ORILISSA
elagolix
Peak
AbbVie
ORAL · TABLET
moderate to severe pain associated with endometriosis
2018
NDA0/100
ORKAMBI
lumacaftor and ivacaftor
Peak
Vertex Pharmaceuticals
ORAL · TABLET
2015
NDA0/100
ORKAMBI
lumacaftor and ivacaftor
Peak
Vertex Pharmaceuticals
ORAL · GRANULE
2018
NDA0/100
ORLADEYO
berotralstat hydrochloride
Peak
BioCryst Pharmaceuticals
ORAL · CAPSULE
2020
NDA0/100
ORSERDU
elacestrant
Peak
Stemline Therapeutics
ORAL · TABLET
2023
NDA0/100
ORTIKOS
budesonide
Peak
PharmaIN
ORAL · CAPSULE, DELAYED RELEASE
2019
NDA0/100
OSMOLEX ER
amantadine hydrochloride
Peak
Supernus Pharmaceuticals
ORAL · TABLET, EXTENDED RELEASE
2018
NDA0/100